Yashoda Super Speciality Hospital, Hyderabad, India.
Strahlenther Onkol. 2012 Jun;188(6):484-90. doi: 10.1007/s00066-012-0075-6. Epub 2012 Mar 10.
The goal of the work was to assess the role of RapidArc treatments in chest wall irradiation after mastectomy and determine the potential benefit of flattening filter free beams.
Planning CT scans of 10 women requiring post-mastectomy chest wall radiotherapy were included in the study. A dose of 50 Gy in 2 Gy fractions was prescribed. Organs at risk (OARs) delineated were heart, lungs, contralateral breast, and spinal cord. Dose-volume metrics were defined to quantify the quality of concurrent treatment plans assessing target coverage and sparing of OARs. Plans were designed for conformal 3D therapy (3DCRT) or for RapidArc with double partial arcs (RA). RapidArc plans were optimized for both conventional beams as well as for unflattened beams (RAF). The goal for this planning effort was to cover 100% of the planning target volume (PTV) with ≥ 90% of the prescribed dose and to minimize the volume inside the PTV receiving > 105% of the dose. The mean ipsilateral lung dose was required to be lower than 15 Gy and V(20 Gy) < 22%. Contralateral organ irradiation was required to be kept as low as possible.
All techniques met planning objectives for PTV and for lung (3DCRT marginally failed for V(20 Gy)). RA plans showed superiority compared to 3DCRT in the medium to high dose region for the ipsilateral lung. Heart irradiation was minimized by RAF plans with ~4.5 Gy and ~15 Gy reduction in maximum dose compared to RA and 3DCRT, respectively. RAF resulted in superior plans compared to RA with respect to contralateral breast and lung with a reduction of ~1.7 Gy and 1.0 Gy in the respective mean doses.
RapidArc treatment resulted in acceptable plan quality with superior ipsilateral tissue sparing compared to traditional techniques. Flattening filter free beams, recently made available for clinical use, might provide further healthy tissue sparing, particularly in contralateral organs, suggesting their applicability for large and complex targets.
本研究旨在评估适形调强放疗(RapidArc)在乳腺癌根治术后胸壁放疗中的作用,并确定使用非均整滤过射束的潜在获益。
本研究纳入了 10 例行乳腺癌根治术后胸壁放疗的女性患者的计划 CT 扫描。处方剂量为 50 Gy,2 Gy/次。勾画的危及器官(OAR)包括心脏、肺、对侧乳房和脊髓。定义剂量体积学指标来量化目标覆盖和 OAR 保护的质量,以评估同期治疗计划。设计了适形 3D 治疗(3DCRT)或双半弧适形调强放疗(RapidArc,RA)计划。RA 计划分别采用常规射束和非均整射束(RapidArc 无均整滤过,RAF)进行优化。本研究的计划目标是 100%的计划靶体积(PTV)接受≥90%的处方剂量,同时使 PTV 内接受>105%剂量的体积最小化。要求同侧肺的平均剂量低于 15 Gy,V(20 Gy)<22%。尽量降低对侧器官的照射剂量。
所有技术均满足 PTV 和肺(3DCRT 仅在 V(20 Gy)上略有失败)的计划目标。与 3DCRT 相比,RA 计划在同侧肺的中高剂量区具有优势。与 RA 和 3DCRT 相比,RFA 计划通过减少 4.5 Gy 和 15 Gy 的最大剂量,最大限度地减少了心脏照射。与 RA 相比,RFA 计划在保护对侧乳房和肺方面具有优势,同侧和对侧的平均剂量分别降低了约 1.7 Gy 和 1.0 Gy。
与传统技术相比,RapidArc 治疗可获得可接受的计划质量,且同侧组织保护效果更佳。最近可用于临床的非均整滤过射束可能会提供进一步的健康组织保护,特别是在对侧器官中,提示其在大而复杂的靶区中的适用性。